J Cancer 2014; 5(2):125-132. doi:10.7150/jca.8242 This issue


Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?

Henning M. Schramm

Institute Hiscia, Society for Cancer Research, CH-4144 Arlesheim/Switzerland.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Schramm HM. Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?. J Cancer 2014; 5(2):125-132. doi:10.7150/jca.8242. Available from https://www.jcancer.org/v05p0125.htm

File import instruction


Cancer cells express epithelial markers, and when progressing in malignancy they may express markers of the mesenchymal cell type. Therefore an epithelial-mesenchymal transition of the cancer cells is assumed. However the mesenchymal markers can equally well be interpreted as myeloid markers since they are common in both types of cell lineages. Moreover, cancer cells express multiple specific markers of the myeloid lineages thus giving rise to the hypothesis that the transition of cancer cells may be from epithelial to myeloid cells and not to mesenchymal cells. This interpretation would better explain why cancer cells, often already in their primary cancer site, frequently show properties common to those of macrophages, platelets and pre-/osteoclasts.

Keywords: Epithelial-mesenchymal transition, epithelial-myeloid transition, osteomimetic properties of cancer cells, macrophage and platelet traits of cancer cells, common clusters of differentiation between cancer cells and cells of the myeloid lineage